Pillsbury advised Elisity, the pioneer in identity-based micro-segmentation, in raising $37 million for a Series B funding round led by global software investor Insight Partners.

Existing investors AllegisCyber Capital and Two Bear Capital also participated.

Coverage by WSJ Pro states that healthcare and manufacturing organizations continue to grapple with cyberattacks on companies of all sizes. As such, Elisity has successfully partnered with healthcare organizations and supports a number of critical infrastructure providers.

Elisity’s additional capital is expected to be put towards extending its platform’s AI capabilities, fully leveraging organizations’ device identity data to anticipate and pre-empt emerging cyber threats, and establish control over IT, OT, IoT and hybrid environments, according to a company press release.

To learn more, click here and here.

The Pillsbury deal team was led by Corporate partner Stan Pierson and included associates Grace Lee and Thomas Morris and senior legal analyst Seetha Balasubramanian.